Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Neuland Laboratories Limited is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This workload is handled by 1 distinct examiner and 1 distinct art unit, which indicates a concentrated prosecution strategy at this stage. The presence of 1 distinct art unit suggests that the company's current patenting efforts are focused on a specific technical category. This localized approach allows the applicant to focus their resources on a single point of review within the patent office, which can simplify the administrative tracking of the 1 pending office action.
The busiest examiner for this portfolio is KONOPELSKI SNAVEL, SARA ELIZABETH, who is assigned 1 pending office action. This 1 pending office action represents the total volume of active office actions for the company. Because the prosecution involves 1 distinct examiner, the company can tailor its responses to the specific examination style of this individual. The alignment of the portfolio within the Biotechnology & Pharmaceuticals area simplifies the management of the pending matter. Practitioners should focus on the specific requirements of KONOPELSKI SNAVEL, SARA ELIZABETH to advance the application effectively.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +38.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997852 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | KONOPELSKI SNAVEL, SARA ELIZABETH | 32d overdue |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17997852 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103 | Final Rejection | 32d overdue | Pending | Nov 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial